Class Action: Combivent Respimat Asthma Inhaler Contains Far Fewer Doses Than Advertised [UPDATE]
May 3, 2019 A COPD sufferer alleges Boehringer Ingelheim's Combivent Respimat asthma inhaler contains far fewer than the 120 doses promised in the advertising and marketing of the treatment.